CONNECTED SYSTEMS · ACCOUNTABLE ACCESS
Nanomedicine and Red Nano QBD
← All Red Pharma modules
Nanomedicine quality-by-design, formulation knowledge, critical attributes, risk, evidence and accountable AI support.
Core capabilities
- QbD and risk knowledge
- Critical material and quality attributes
- Nanomedicine evidence and AI ledger
Submodules and specialised features
Material, formulation and sample entity lineage
Controlled planning and evidence
Controlled planning/evidence record with versions, signatures, audit and metrics. This badge alone does not mean a numerical engine, instrument connection or editable CAD feature. Separately named computation workspaces show their supported operations and limits.
Nanomedicine QTPP, CQA, CMA and CPP mapping
Controlled planning and evidence
Controlled planning/evidence record with versions, signatures, audit and metrics. This badge alone does not mean a numerical engine, instrument connection or editable CAD feature. Separately named computation workspaces show their supported operations and limits.
Experiment design, model and design-space evidence
Controlled planning and evidence
Controlled planning/evidence record with versions, signatures, audit and metrics. This badge alone does not mean a numerical engine, instrument connection or editable CAD feature. Separately named computation workspaces show their supported operations and limits.
DLS, PDI, zeta and orthogonal characterization context
Controlled planning and evidence
Controlled planning/evidence record with versions, signatures, audit and metrics. This badge alone does not mean a numerical engine, instrument connection or editable CAD feature. Separately named computation workspaces show their supported operations and limits.
Instrument/result registry integration
Customer connector required
Represented as a controlled requirement and status, but live execution requires a separately qualified customer connector or device integration.
Nanomedicine QbD study
Study Design → Scientific Review → Study Accepted
Transitions retain their configured review, signature and separation-of-duty requirements.
Access and deployment
Maximum active named users assigned to Nanomedicine or Red Nano QBD positions.
Shared Enterprise tools · Mobile and desktop availability